Search research articles
Contact Us
Filters
Showing results (141-150 of 218) with videos related to
Page
of 22
Sort By:
Plos One
|
December 2, 2011
hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene
Indrani Talukdar, Supriya Sen, Rodolfo Urbano, et al.
IEEE Transactions on Bio-Medical Engineering
|
July 1, 1991
A microprocessor-based data-acquisition system for measuring plantar pressures from ambulatory subjects
H S Zhu, G F Harris, J J Wertsch, et al.
IEEE Transactions on Bio-Medical Engineering
|
October 1, 1983
Sensitivity of frequency dependence of lung compliance in detecting uneven time constants
P V Bhansali, J A Dempsey, L Chosey, et al.
Journal of Biomedical Engineering
|
January 1, 1981
Renal preservation resistance: evidence against myogenic vasoactive factors
S W Flax, T L Goodfriend, D T Uehling, et al.
IEEE Transactions on Bio-Medical Engineering
|
April 12, 2001
Guidelines for predicting lesion size at common endocardial locations during radio-frequency ablation
S Tungjitkusolmun, V R Vorperian, N Bhavaraju, et al.
Molecular Endocrinology (Baltimore, Md.)
|
March 5, 2002
GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells
Fujun Liu, Darrell A Austin, Pamela L Mellon, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Catestatin suppresses melanoma progression and drug resistance through multitargeted modulation of signaling pathways
Satadeepa Kal, Suborno Jati, Kechun Tang, et al.
IEEE Transactions on Bio-Medical Engineering
|
April 1, 1989
Development of a three-channel, 24-h ambulatory esophageal pressure monitor
C J Pfister, M A Harrison, J W Hamilton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 2007
Neuroprotection by small molecule activators of the nerve growth factor receptor
Bo Lin, Michael C Pirrung, Liu Deng, et al.
Oncogenesis
|
May 21, 2026
Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways
Satadeepa Kal, Suborno Jati, Kechun Tang, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 218) with videos related to
Sort By:
Page
of 22
Plos One
|
December 2, 2011
hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene
Indrani Talukdar, Supriya Sen, Rodolfo Urbano, et al.
IEEE Transactions on Bio-Medical Engineering
|
July 1, 1991
A microprocessor-based data-acquisition system for measuring plantar pressures from ambulatory subjects
H S Zhu, G F Harris, J J Wertsch, et al.
IEEE Transactions on Bio-Medical Engineering
|
October 1, 1983
Sensitivity of frequency dependence of lung compliance in detecting uneven time constants
P V Bhansali, J A Dempsey, L Chosey, et al.
Journal of Biomedical Engineering
|
January 1, 1981
Renal preservation resistance: evidence against myogenic vasoactive factors
S W Flax, T L Goodfriend, D T Uehling, et al.
IEEE Transactions on Bio-Medical Engineering
|
April 12, 2001
Guidelines for predicting lesion size at common endocardial locations during radio-frequency ablation
S Tungjitkusolmun, V R Vorperian, N Bhavaraju, et al.
Molecular Endocrinology (Baltimore, Md.)
|
March 5, 2002
GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells
Fujun Liu, Darrell A Austin, Pamela L Mellon, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Catestatin suppresses melanoma progression and drug resistance through multitargeted modulation of signaling pathways
Satadeepa Kal, Suborno Jati, Kechun Tang, et al.
IEEE Transactions on Bio-Medical Engineering
|
April 1, 1989
Development of a three-channel, 24-h ambulatory esophageal pressure monitor
C J Pfister, M A Harrison, J W Hamilton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 2007
Neuroprotection by small molecule activators of the nerve growth factor receptor
Bo Lin, Michael C Pirrung, Liu Deng, et al.
Oncogenesis
|
May 21, 2026
Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways
Satadeepa Kal, Suborno Jati, Kechun Tang, et al.
Page
of 22